FOCUS COLUMN
By Peter M. Stone and Ryan M. Fawaz
This article appears on Page 7
In Dura Pharmaceuticals v. Broudo, 544 U.S. 336 (2005), the Supreme Court held a plaintiff must do more than merely plead or prove an artificial inflation of a company's stock to satisfy the loss causation requirement for securities fraud. Within the last few weeks, the 9th Circuit decided two cases further examining the scop...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




